Jo Caers

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications

Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 study.

Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 study.

Journal: Future oncology (London, England)
Published: August 30, 2026

Infusion of human mesenchymal stromal cells during normothermic machine perfusion of porcine kidneys: a randomized, blinded, preclinical study.

Infusion of human mesenchymal stromal cells during normothermic machine perfusion of porcine kidneys: a randomized, blinded, preclinical study.

Journal: Scientific reports
Published: May 12, 2026

Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients.

Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patients.

Journal: Annals of hematology
Published: March 25, 2026

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

Journal: Blood cancer journal
Published: March 23, 2026

Acquired hemophilia A secondary to marginal zone lymphoma

Acquired hemophilia A secondary to marginal zone lymphoma

Journal: Revue medicale de Liege
Published: March 12, 2026

Comparable restimulation of human T cells activated with CD3/CD28 beads versus soluble antibody complexes.

Comparable restimulation of human T cells activated with CD3/CD28 beads versus soluble antibody complexes.

Journal: Scientific reports
Published: November 28, 2025

Correction: From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors.

Correction: From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors.

Journal: Frontiers in immunology
Published: November 03, 2025

Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma.

Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma.

Journal: Cells
Published: October 22, 2025

Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function.

Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function.

Journal: Frontiers in immunology
Published: October 01, 2025

Novel diagnostic approaches and therapeutic management of mucormycosis: insights from a retrospective monocentric cohort study.

Novel diagnostic approaches and therapeutic management of mucormycosis: insights from a retrospective monocentric cohort study.

Journal: Frontiers in medicine
Published: September 29, 2025

Reviewing the Efficiency of the Initial Work-Up for Hereditary Hemorrhagic Telangiectasia in a Tertiary Referral University Center in Belgium.

Reviewing the Efficiency of the Initial Work-Up for Hereditary Hemorrhagic Telangiectasia in a Tertiary Referral University Center in Belgium.

Journal: Ear, nose, & throat journal
Published: July 31, 2025

Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

Journal: Breast cancer research : BCR
Published: June 04, 2025
Showing 1-12 of 115

Last Updated: 09/26/2026